HeartBeam, Inc. 8-K Summary
Business Context and Reporting Period
HeartBeam, Inc. filed a Current Report on Form 8-K under Item 5.02. The earliest reported event was February 1, 2024. The company develops cardiac monitoring technology; this filing concerns a senior-management transition rather than operating or financial results.
Management Change
- Richard Brounstein retired as Chief Financial Officer effective February 1, 2024.
- Mr. Brounstein had served on HeartBeam’s executive team since 2015.
- He will provide CFO advisory services as a consultant to support the transition.
- The filing states that the retirement was not due to any disagreement with the company, its Board of Directors, or matters relating to operations, policies, or practices.
- The filing does not identify a successor CFO or disclose compensation, severance, or other financial terms related to the transition.
Financial Metrics and Liquidity
This 8-K does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other financial results. The filing text does not provide a clear value for any such metrics.
Outlook, Risks, and Unusual Items
The principal disclosed item is the CFO retirement and related transition consulting arrangement. No changes to business outlook, financial guidance, contingencies, or specific risks are disclosed.
Key Facts to Verify
- Whether and when HeartBeam appoints a permanent successor to the CFO position.
- The scope, duration, and cost of Mr. Brounstein’s CFO advisory services.
- Any subsequent disclosure regarding transition-related compensation or other arrangements.
- Future periodic filings for the company’s financial condition, liquidity, and operating performance.
The report was signed on February 2, 2024, by Branislav Vajdic, Chief Executive Officer.